Keita Masuzawa, MD, PhD

Dr. Masuzawa is a postdoctoral fellow who started in the Oser laboratory in April of 2022. His post-doctoral work is focused on using CRISPR/Cas9 screening approaches to understand the transcriptional regulation of oncoproteins in SCLC. He is from Japan where he trained at Keio University as a pulmonologist and received his PhD also at Keio University in 2019.